Arab World vs Switzerland: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
Switzerland
90.0%
in 2023
Arab World rank
16th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Arab World
- Switzerland
How they compare
Switzerland currently reports 90.0% against 49.3% in Arab World, a difference of 40.7%.
That makes Switzerland's figure about 1.8 times Arab World's.
Across all 24 years both countries report, Switzerland has been ahead every year.
Arab World ranks 16th and Switzerland ranks 13th of 19 groups.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 50.0% | 43.1% | Switzerland |
| 2010s | 24.3% | 79.2% | 54.9% | Switzerland |
| 2020s | 43.0% | 90.2% | 47.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or Switzerland?
- Switzerland, at 90.0% against 49.3% in Arab World as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Arab World and Switzerland?
- 40.7%, with Switzerland ahead.
- How many years of comparable data are there for Arab World and Switzerland?
- 24 years are reported by both, from 2000 to 2023.
- How do Arab World and Switzerland rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and Switzerland ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.